Market Chameleon (Tue, 30-Jun 6:33 AM ET)
Globe Newswire (Tue, 30-Jun 9:15 AM ET)
Market Chameleon (Mon, 29-Jun 5:52 AM ET)
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
Globe Newswire (Mon, 29-Jun 7:08 AM ET)
PetMeds Announces Fourth Quarter and Fiscal Year 2026 Financial Results
Globe Newswire (Tue, 2-Jun 4:05 PM ET)
Globe Newswire (Fri, 29-May 8:00 AM ET)
Globe Newswire (Wed, 22-Apr 4:05 PM ET)
PetMeds Unveils Wellness-Focused Holiday Collection Aimed at Health-Conscious Pet Parents
Market Chameleon (Thu, 11-Dec 4:53 AM ET)
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Petmed Express trades on the NASDAQ stock market under the symbol PETS.
As of July 8, 2026, PETS stock price declined to $1.90 with 41,493 million shares trading.
PETS has a beta of 1.67, meaning it tends to be more sensitive to market movements. PETS has a correlation of 0.06 to the broad based SPY ETF.
PETS has a market cap of $40.60 million. This is considered a Sub-Micro Cap stock.
Last quarter Petmed Express reported $43 million in Revenue and -$.19 earnings per share. This beat revenue expectation by $34 million and missed earnings estimates by -$.01.
In the last 3 years, PETS traded as high as $15.08 and as low as $1.57.
The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, ITOT, BSVO, FSCC.
PETS has underperformed the market in the last year with a return of -44.0%, while the SPY ETF gained +20.4%. In the last 3 month period, PETS fell short of the market, returning -18.1%, while SPY returned +12.5%. However, in the most recent 2 weeks PETS has outperformed the stock market by returning +3.8%, while SPY returned +0.8%.
PETS support price is $1.84 and resistance is $2.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.